Monitoring of multidrug-resistant Gram-negative bacteria of medical importance (human & veterinary): clinical/environmental impact and development of therapeutic alternatives and technology innovation products

• Grant number: 13/04725-0
• Support Opportunities: Regular Research Grants
• Duration: June 01, 2013 - May 31, 2015
• Field of knowledge: Biological Sciences - Microbiology - Applied Microbiology
• Principal Investigator: Nilton Erbet Lincopan Huenuman
• Grantee: Nilton Erbet Lincopan Huenuman
• Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

The emergence of multidrug-resistant bacteria (MDR) is a global public health issue, consequence of the overuse and misuse of antibiotics. Following the Darwinian principle of survival of the fittest this practice has favored the natural selection and endemicity of MDR bacterial in clinical settings (human and veterinary), whereas the rapid spread of genes encoding new and broad-spectrum mechanisms of resistance has contributed to therapeutic failure. In this context, Brazil has been one of the most affected countries, which has been discussed repeatedly in scientific meetings, with data widely documented in national and international journals, where carbapenemase (IMP-1, OXA -23, OXA-143, SPM-1 or KPC-2)- and/or extended-spectrum beta-lactamases (CTX-M-type)-producing gram-negative bacteria are associated with high morbidity and mortality rates and outbreaks of hospital infection. Although clinical, microbiological and epidemiological data related to MDR bacteria and health care-associated infections (HCAI) have been elucidated, the environmental impact and the potential role of reservoirs (i.e., environmental sources, pets or food-producing animals) in very close contact with human beings has been neglected and needs to be evaluated with priority. Thus, the aim of this study is to monitor the prevalence of MDR gram-negative bacteria, with transferable plasmid-mediated resistance to human and veterinary broad-spectrum beta-lactam and fluoroquinolone agents, in clinical samples, aquatic environments and companion animals in São Paulo state, elucidating the clonal relationships, and proposing alternative therapies based on bactericidal activity of drug combinations exhibiting a synergistic effect; use of bilayer fragments of cationic lipids (bicelles); lytic bacteriophages; biomimetic bacteriophage nanoparticles (patent request PI: 1020120238152), and/or their combinations, under physicochemical conditions supporting the development of pharmaceutical products of technological innovation, with potential useful applications. The results will contribute to epidemiological data on resistance to antibiotics in bacteria that can be isolated from aquatic public environments and companion animals, determining the clinical/environmental impact resulting from the overuse and misuse of compounds with antimicrobial activity; identifying the sources/vehicles and public places with potential for human transmission, or to spread to other animals or associated ecosystems in the city of São Paulo. Moreover, search for therapeutic alternatives will contribute to the establishment of therapeutic schedules and/or recommendations for the use of effective antibiotic combinations for the treatment of infections produced by MDR bacteria, which have become endemic in Brazil. Finally, physicochemical and antibacterial studies of bilayer fragments of cationic lipids, nanoparticles, and lytic bacteriophages, against MDR bacteria, will provide the basis for development of pharmaceutical products of technological innovation with potential clinical applicability. (AU)

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

CASTELANI, L.; ARCARO, J. R. P.; BRAGA, J. E. P.; ROSSO, A. S.; MOURA, Q.; ESPOSITO, F.; SAUTER, I. P.; CORTEZ, M.; LINCOPAN, N.. Short communication: Activity of nisin, lipid bilayer fragments and cationic nisin-lipid nanoparticles against multidrug-resistant Staphylococcus spp. isolated from bovine mastitis. JOURNAL OF DAIRY SCIENCE, v. 102, n. 1, p. 678-683, JAN 2019. (16/08593-9, 13/04725-0, 13/15504-4)

MELO, LUANA C.; ORESCO, CINTIA; LEIGUE, LUCIANNE; NETTO, HILDEBRANDO M.; MELVILLE, PRISCILLA A.; BENITES, NILSON R.; SARAS, ESTELLE; HAENNI, MARISA; LINCOPAN, NILTON; MADEC, JEAN-YVES. Prevalence and molecular features of ESBL/pAmpC-producing Enterobacteriaceae in healthy and diseased companion animals in Brazil. Veterinary Microbiology, v. 221, p. 59-66, JUL 2018. (16/08593-9, 13/04725-0)

NASCIMENTO, TATIANE; CANTAMESSA, RODRIGO; MELO, LUANA; FERNANDES, MIRIAM R.; FRAGA, EDMIR; DROPA, MILENA; SATO, MARIA I. Z.; CERDEIRA, LOUISE; LINCOPAN, NILTON. International high-risk clones of Klebsiella pneumoniae KPC-2/CC258 and Escherichia coli CTX-M-15/CC10 in urban lake waters. Science of The Total Environment, v. 598, p. 910-915, NOV 15 2017. (12/23588-0, 16/08593-9, 13/04725-0)